Biopharma Portfolio

Targeting Hemophilia Treatment	Octapharma Gains Orphan Drug Exclusivity	FDA Approves Wilate
Research Grants Program	Development of Human Proteins	Plasma Centers Acquired
Head of U.S. Operations Appointed	Fighting Childhood Immune Disease	Research Grants Program
Plasma Centers Acquired	Therapies for Immune Deficiency	VP Medical Affairs Named
Swiss Company Moves U.S. Headquarters	Octapharma Expanding Portfolio	License, Development Plan Sealed